Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Treatment of Facial Burns With Flammacerium Compared to Flammazine and the Impact of Facial Burns on Psychosocial Wellbeing [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing Flammacerium to Flammazine for facial burns and assessing psychosocial impact.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flammacerium
  • Flammazine

Snippet

Sponsor: Association of Dutch Burn Centres | Conditions: Burns | Phase 4 | Status: COMPLETED